Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer

Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record for sacituzumab govitecan in adults with epithelial cancer is displayed, including its completed status, eligibility criteria, treatment plan, outcomes, and publications. Study documents and record history are also available.
    Difference
    81%
    Check dated 2026-11-08T13:27:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates to terminology for artificial intelligence during a transition. The clinical study record itself remains inaccessible and displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:35:42.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:47:09.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:14:00.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error in place of the study record for sacituzumab govitecan in adults with epithelial cancer.
    Difference
    22%
    Check dated 2026-10-04T16:05:27.000Z thumbnail image

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer

Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.